HealthTech

VectorAnalytics

VectorAnalytics Raises $350M Series E to Transform HealthTech

$350M Series E
Total Raised
Series
Latest Round
2020
Founded
250-500
Employees
New York, NY
1 min read

Quick Facts

Valuation
$7B
Latest Round Size
$350M Series E
Latest Round Date
October 2025

VectorAnalytics Raises $350M Series E in Latest Funding Round

VectorAnalytics has successfully closed a $350M Series E funding round, marking a significant milestone in the company's growth trajectory. The round was led by Lightspeed Venture Partners, with participation from Khosla Ventures.

Company Overview

Founded in 2020 and headquartered in New York, NY, VectorAnalytics has established itself in the HealthTech space. Leading telemedicine solution connecting patients with healthcare providers remotely

With a current valuation of $7B, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $350M Series E
  • Valuation: $7B
  • Lead Investor: Lightspeed Venture Partners

Future Outlook

As VectorAnalytics moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Lightspeed Venture Partners
Venture Capital
Leading venture capital firm investing in technology companies
Khosla Ventures
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

David Chen
David Chen
Technology investment researcher specializing in enterprise software and infrastructure deals at top-tier venture funds.